|
|
 |
Reducing bacterial colonization in the mouth and on the surface of the teeth of ICU patients decreases the frequency of VAP.15 While oral care is now a high priority in U.S. facilities, only one brand is delivering the outcomes that prove it. Toothette® Oral Care addresses risk factors with a comprehensive approach based on cleaning, debriding, suctioning and moisturizing the entire oral cavity. All tools and interventions are designed to make it easier to maintain a healthy oral cavity.
“…The mere reduction of risk through better oral hygiene can lead to fewer VAPs.”1 |
PROVEN CLINCAL RESULTS
Reducing VAP
One hospital implemented comprehensive oral care and reduced VAP by over 60%. Their protocol featured Toothette brand products and called for oral care every 2 to 4 hours.3,*
In a 4-year, 1,614-patient study in AACN News, Toothette Oral Care helped achieve a statistically significant 42.1% VAP reduction—preventing 21 cases in the MICU and avoiding $722,975 in costs.1
Reducing HAP
In a 2-year study at 11 nursing homes, pneumonia risk was significantly reduced in patients receiving oral care. In fact, mortality due to pneumonia was about half that of patients not receiving oral care.5
Cost Avoidance
In 17 months, one 350-bed hospital reduced VAP over 75%, avoiding $1.6 million in costs. Along with a ventilator bundle and head-of-bed elevation, they upgraded from swabs only to Q•Care® cleansing and suctioning every 2 to 4 hours.6
* Other contributing risk factors exist, but were not addressed in this study.
Superior Sage Quality: Antiseptic Oral Rinse, Antiplaque Solution, and Perox-A-Mint are FDA-regulated OTC drugs. We maintain strict adherence to all applicable FDA standards and Good Manufacturing Practices. While such compliance is required to manufacture medical drugs and devices, we voluntarily apply the same high standards to all of our products, including those classified as cosmetics. This commitment helps ensure the level of quality vital for patients at high risk for developing nosocomial infections.
|
|
| |
Innovative Tools
Suction Toothbrush: Helps remove dental plaque7,8 debris and oral secretions, all known to harbor potential respiratory pathogens.4, 9,10,11
Suction Swabs: Help remove debris and oral secretions—while stimulating oral tissues3,12,13-between brushings.
Covered Yankauer: Removes debris and oral secretions. Between uses, its exclusive sleeve retracts to help contain secretions and protect itself from environmental debris.
Oropharyngeal Suction Catheter: Soft and flexible, it facilitates suctioning of oropharyngeal secretions above the vocal cords.
|
Effective Solutions
Antiseptic Oral Rinse: Helps reduce the chance of infection in minor oral irritation with .05% cetylpyridinium chloride. Promotes healing by reducing bacteria known to cause most oral dysfunction.14, 15
Antiplaque Solution: Helps remove and prevent plaque that leads to gingivitis with .05% cetylpyridinium chloride.
Perox-A-Mint® Solution: Mechanically cleans and debrides with 1.5% hydrogen peroxide.
CHG Oral Rinse: : 0.12% chlorhexidine gluconate treats gingivitis characterized by redness and swelling of the gingivae, including gingival bleeding.
Alcohol-Free Mouthwash: Cleans and refreshes without drying or irritating.
Mouth Moisturizer: Water-based formula soothes and moisturizes lips and oral tissue with vitamin E and coconut oil.
|
| |
| REFERENCES: 1. Vollman K, Garcia R, Miller L, AACN News, 2005 Aug;22(8):12-6. 2. Healthcare Products Information Services (HPIS), Hospital Market Trend Report, 2nd Qtr 2006. 3. Schleder B, et al., J Advocate Health Care. 2002 Spr/Sum;4(1):27-30. 4. Scannapieco FA, et al., Crit Care Med. 1992 Jun ;20(6):740-5. 5. Yoneyama T, et al., J Am Geriatrics Soc. 2002;50(3):434-8. 6. Sherman Hospital saves $1.6 million on VAP-related costs. Case study, 2005 (available at http://www.sageproducts.com/company/media2.asp?ArticleID=51). 7. DeWalt EM, Nurs Res. 1975 Mar-Apr;24(2):104-8. 8. Pearson LS, Hutton JL, J Adv Nurs. 2002 Sep;39(5):480-9. 9. Scannapieco FA, J Periodontology. 1999 Jul;70(7):793-802. 10. Fourrier F, et al., Crit Care Med. 1998;26:301-8 11. Sole ML, et al., Am J Crit Care. 2002 Mar;11(2):141-9. 12. DeWalt EM, Nurs Res. 1975 Mar-Apr;24(2):104-8. 13. Schleder BJ, Nursing Mgmt. 2003 Aug;34(8):27-33. 14. Nisengard RJ, Dept of Periodontics & Endodontics, Sch of Dent Med, SUNY Buffalo, 2000 Dec. 15. Candida albicans, Streptococcus mutans and Actinomyces viscosus. 16. Cason, CL, et al., Am J Crit Care. 2007 Jan;16(1):28-38. 17. Tablan OC, et al., Guidelines for Preventing Health-Care--Associated Pneumonia, 2003. CDC, MMWR. 26 Mar 2004;53(RR03);1-36. |
| |
|
